Universal Beteiligungs und Servicegesellschaft mbH Acquires New Stake in Electromed, Inc. (NYSE:ELMD)

Key Points

• Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Electromed, Inc. by purchasing 16,493 shares valued at approximately $394,000, representing about 0.19% of the company's stock.
• Several large investors, including Arrowstreet Capital and Lazard Asset Management, have made significant increases in their holdings of Electromed during the fourth quarter.
• Analysts have mixed ratings on Electromed, with B. Riley upgrading it to a "strong-buy" while Wall Street Zen downgraded it to a "buy," indicating a range of opinions on the stock's performance outlook.

Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Electromed, Inc. (NYSE:ELMD - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 16,493 shares of the company's stock, valued at approximately $394,000. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.19% of Electromed at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of ELMD. Russell Investments Group Ltd. bought a new position in Electromed in the fourth quarter valued at $37,000. Bank of America Corp DE boosted its stake in shares of Electromed by 179.2% during the 4th quarter. Bank of America Corp DE now owns 4,004 shares of the company's stock worth $118,000 after buying an additional 2,570 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Electromed in the fourth quarter valued at about $119,000. Tower Research Capital LLC TRC raised its holdings in Electromed by 426.6% during the fourth quarter. Tower Research Capital LLC TRC now owns 5,055 shares of the company's stock worth $149,000 after acquiring an additional 4,095 shares in the last quarter. Finally, Two Sigma Advisers LP acquired a new position in Electromed during the fourth quarter valued at approximately $219,000. 40.82% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on ELMD shares. B. Riley upgraded shares of Electromed to a "strong-buy" rating in a research note on Thursday, May 15th. Wall Street Zen cut Electromed from a "strong-buy" rating to a "buy" rating in a research report on Thursday, May 8th. Finally, Roth Capital started coverage on Electromed in a research note on Tuesday, July 22nd. They issued a "buy" rating and a $29.00 price target on the stock.

Electromed Stock Down 1.0%

ELMD traded down $0.18 during midday trading on Wednesday, hitting $18.43. The company had a trading volume of 29,367 shares, compared to its average volume of 85,108. The stock's 50 day moving average price is $19.92 and its 200 day moving average price is $23.80. Electromed, Inc. has a 52 week low of $13.74 and a 52 week high of $35.56. The company has a market capitalization of $154.55 million, a price-to-earnings ratio of 24.57 and a beta of 0.38.

Electromed Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.